Original Research

DOI: 10.4244/EIJ-D-24-01155

Coronary microvascular disease in patients referred to coronary angiography following coronary computed tomography angiography

Jelmer Westra1,2, MD, PhD; Laust Dupont Rasmussen3,4, MD, PhD; Salma Raghad Karim1,5, MD; Rebekka Viberg Jensen1,5, MD, PhD; June Anita Ejlersen5, MD, PhD; Lars Christian Gormsen6,7, MD, PhD; Morten Bøttcher3,7, MD, PhD; Ashkan Eftekhari4, MD, PhD; Simon Winther3,5, MD, PhD; Evald Høj Christiansen1,5, MD, PhD

Abstract

Background: Ischaemia without obstructive epicardial coronary artery disease (CAD) is common and is often related to coronary microvascular disease (CMD). Previous studies primarily focused on functional assessment in patients with established ischaemia without obstructive epicardial CAD.

Aims: We sought to assess the prevalence of CMD and compare clinical and procedural characteristics including myocardial perfusion imaging, as derived from rubidium-82 positron emission tomography (82Rb-PET), and health status according to CAD classification.

Methods: We conducted a prospective, observational study of symptomatic patients with suspected obstructive epicardial CAD on coronary computed tomography angiography. All patients were referred to 82Rb-PET and invasive coronary angiography with bolus thermodilution. CMD was defined as the absence of obstructive epicardial CAD (fractional flow reserve>0.80 or diameter stenosis <90%) combined with coronary flow reserve <2.5 and/or index of microvascular resistance ≥25. Main analyses included myocardial perfusion characteristics by 82Rb-PET and health status at baseline and at 3-month follow-up according to CAD classification (no disease, obstructive epicardial CAD, isolated CMD or combined obstructive epicardial CAD and CMD).

Results: Among 561 patients, isolated CMD was diagnosed in 131 patients (prevalence 0.23, 95% confidence interval [CI]: 0.20-0.27). Vessel territories with isolated CMD were characterised by similar perfusion characteristics to non-diseased vessels (mean difference in hyperaemic myocardial blood flow 0.03 [95% CI: −0.13 to 0.06] mL/min/g). Patients with isolated epicardial disease on both patient and vessel levels had reduced stress myocardial blood flow compared to patients without disease. The probability of being angina-free at 3 months tended to be lower for the CMD group (odds ratio [OR] 0.56, 95% CI: 0.31-1.00) and higher for the revascularised epicardial disease group (OR 1.52, 95% CI: 0.94-2.48) compared to the group classified as not diseased.

Conclusions: CMD, as identified with bolus thermodilution, is common in patients referred to invasive coronary angiography based on suspected obstructive epicardial CAD even in patients with normal stress myocardial blood flow by 82Rb-PET. (ClinicalTrials.gov: NCT02264717 and NCT04707859)

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 17
Sep 1, 2025
Volume 21 Number 17
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-25-00671 Jan 5, 2026
Non-invasive assessment of microcirculatory resistance by coronary computed tomography angiography
Deng D et al
open access

10.4244/EIJV14I5A89 Aug 3, 2018
Microvascular disease, what little we know
Appelman Y
free

Original Research

10.4244/EIJ-D-25-00229 Aug 18, 2025
Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction
Mahendiran T et al

Original Research

10.4244/EIJ-D-25-00277 Sep 1, 2025
Chest pain patterns and coronary microvascular function in non-obstructive coronary artery disease
Nogami K et al

Editorial

10.4244/EIJ-E-22-00056 Feb 6, 2023
ResETTing the diagnostic utility of exercise tolerance testing for INOCA
Ali ZA and Jeremias A
free

Editorial

10.4244/EIJ-D-25-01153 Jan 5, 2026
Computed tomography angiography-derived microvascular resistance: is less always more?
Gallinoro E and Barbato E
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved